The TGF-β signaling pathway is involved in numerous cellular processes, and its deregulation may result in cancer development. One of the key processes in tumor progression and metastasis is epithelial to mesenchymal transition (EMT), in which TGF-β signaling plays important roles. Recently, AGR2 was identified as a crucial component of the cellular machinery responsible for maintaining the epithelial phenotype, thereby interfering with the induction of mesenchymal phenotype cells by TGF-β effects in cancer. Here, we performed transcriptomic profiling of A549 lung cancer cells with CRISPR-Cas9 mediated AGR2 knockout with and without TGF-β treatment. We identified significant changes in transcripts associated with focal adhesion and eicosanoid production, in particular arachidonic acid metabolism. Changes in transcripts associated with the focal adhesion pathway were validated by RT-qPCR of COL4A1, COL4A2, FLNA, VAV3, VEGFA, and VINC mRNAs. In addition, immunofluorescence showed the formation of stress fibers and vinculin foci in cells without AGR2 and in response to TGF-β treatment, with synergistic effects observed. These findings imply that both AGR2 downregulation and TGF-β have a role in focal adhesion formation and cancer cell migration and invasion. Transcripts associated with arachidonic acid metabolism were downregulated after both AGR2 knockout and TGF-β treatment and were validated by RT-qPCR of GPX2, PTGS2, and PLA2G4A. Since PGE2 is a product of arachidonic acid metabolism, its lowered concentration in media from AGR2-knockout cells was confirmed by ELISA. Together, our results demonstrate that AGR2 downregulation and TGF-β have an essential role in focal adhesion formation; moreover, we have identified AGR2 as an important component of the arachidonic acid metabolic pathway.

Department of Comprehensive Cancer Care Faculty of Medicine Masaryk University Kamenice 753 5 62500 Brno Czech Republic

Department of Comprehensive Cancer Care Masaryk Memorial Cancer Institute Zluty Kopec 7 65653 Brno Czech Republic

Department of Radiation Oncology Masaryk Memorial Cancer Institute Zluty Kopec 7 65653 Brno Czech Republic

National Centre for Biomolecular Research Faculty of Science Masaryk University Kamenice 5 62500 Brno Czech Republic

Research Centre for Applied Molecular Oncology Masaryk Memorial Cancer Institute Zluty Kopec 7 65653 Brno Czech Republic

Zobrazit více v PubMed

Chaffer C.L., Weinberg R.A. A perspective on cancer cell metastasis. Science. 2011;331:1559–1564. doi: 10.1126/science.1203543. PubMed DOI

Mani S.A., Guo W., Liao M.J., Eaton E.N., Ayyanan A., Zhou A.Y., Brooks M., Reinhard F., Zhang C.C., Shipitsin M., et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008;133:704–715. doi: 10.1016/j.cell.2008.03.027. PubMed DOI PMC

Brabletz T., Jung A., Reu S., Porzner M., Hlubek F., Kunz-Schughart L.A., Knuechel R., Kirchner T. Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc. Natl. Acad. Sci. USA. 2001;98:10356–10361. doi: 10.1073/pnas.171610498. PubMed DOI PMC

Thiery J.P., Acloque H., Huang R.Y., Nieto M.A. Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139:871–890. doi: 10.1016/j.cell.2009.11.007. PubMed DOI

Chevet E., Fessart D., Delom F., Mulot A., Vojtesek B., Hrstka R., Murray E., Gray T., Hupp T. Emerging roles for the pro-oncogenic anterior gradient-2 in cancer development. Oncogene. 2013;32:2499–2509. doi: 10.1038/onc.2012.346. PubMed DOI

Jach D., Cheng Y., Prica F., Dumartin L., Crnogorac-Jurcevic T. From development to cancer—An ever-increasing role of AGR2. Am. J. Cancer Res. 2021;11:5249–5262. PubMed PMC

Hrstka R., Bouchalova P., Michalova E., Matoulkova E., Muller P., Coates P.J., Vojtesek B. AGR2 oncoprotein inhibits p38 MAPK and p53 activation through a DUSP10-mediated regulatory pathway. Mol. Oncol. 2016;10:652–662. doi: 10.1016/j.molonc.2015.12.003. PubMed DOI PMC

Ramachandran V., Arumugam T., Wang H., Logsdon C.D. Anterior gradient 2 is expressed and secreted during the development of pancreatic cancer and promotes cancer cell survival. Cancer Res. 2008;68:7811–7818. doi: 10.1158/0008-5472.CAN-08-1320. PubMed DOI PMC

Tsuji T., Satoyoshi R., Aiba N., Kubo T., Yanagihara K., Maeda D., Goto A., Ishikawa K., Yashiro M., Tanaka M. Agr2 mediates paracrine effects on stromal fibroblasts that promote invasion by gastric signet-ring carcinoma cells. Cancer Res. 2015;75:356–366. doi: 10.1158/0008-5472.CAN-14-1693. PubMed DOI

Wang Z., Hao Y., Lowe A.W. The adenocarcinoma-associated antigen, AGR2, promotes tumor growth, cell migration, and cellular transformation. Cancer Res. 2008;68:492–497. doi: 10.1158/0008-5472.CAN-07-2930. PubMed DOI

Hrstka R., Brychtova V., Fabian P., Vojtesek B., Svoboda M. AGR2 predicts tamoxifen resistance in postmenopausal breast cancer patients. Dis. Markers. 2013;35:207–212. doi: 10.1155/2013/761537. PubMed DOI PMC

Mizuuchi Y., Aishima S., Ohuchida K., Shindo K., Fujino M., Hattori M., Miyazaki T., Mizumoto K., Tanaka M., Oda Y. Anterior gradient 2 downregulation in a subset of pancreatic ductal adenocarcinoma is a prognostic factor indicative of epithelial-mesenchymal transition. Lab. Invest. 2015;95:193–206. doi: 10.1038/labinvest.2014.138. PubMed DOI

Noguchi S., Eitoku M., Moriya S., Kondo S., Kiyosawa H., Watanabe T., Suganuma N. Regulation of Gene Expression by Sodium Valproate in Epithelial-to-Mesenchymal Transition. Lung. 2015;193:691–700. doi: 10.1007/s00408-015-9776-9. PubMed DOI

Norris A.M., Gore A., Balboni A., Young A., Longnecker D.S., Korc M. AGR2 is a SMAD4-suppressible gene that modulates MUC1 levels and promotes the initiation and progression of pancreatic intraepithelial neoplasia. Oncogene. 2013;32:3867–3876. doi: 10.1038/onc.2012.394. PubMed DOI PMC

Sommerova L., Ondrouskova E., Vojtesek B., Hrstka R. Suppression of AGR2 in a TGF-beta-induced Smad regulatory pathway mediates epithelial-mesenchymal transition. BMC Cancer. 2017;17:546. doi: 10.1186/s12885-017-3537-5. PubMed DOI PMC

Sommerova L., Ondrouskova E., Martisova A., Zoumpourlis V., Galtsidis S., Hrstka R. ZEB1/miR-200c/AGR2: A New Regulatory Loop Modulating the Epithelial-Mesenchymal Transition in Lung Adenocarcinomas. Cancers. 2020;12:1614. doi: 10.3390/cancers12061614. PubMed DOI PMC

Ma S.R., Mao L., Deng W.W., Li Y.C., Bu L.L., Yu G.T., Zhang W.F., Sun Z.J. AGR2 promotes the proliferation, migration and regulates epithelial-mesenchymal transition in salivary adenoid cystic carcinoma. Am. J. Transl. Res. 2017;9:507–519. PubMed PMC

Matsuda Y., Miura K., Yamane J., Shima H., Fujibuchi W., Ishida K., Fujishima F., Ohnuma S., Sasaki H., Nagao M., et al. SERPINI1 regulates epithelial-mesenchymal transition in an orthotopic implantation model of colorectal cancer. Cancer Sci. 2016;107:619–628. doi: 10.1111/cas.12909. PubMed DOI PMC

Mi H., Muruganujan A., Huang X., Ebert D., Mills C., Guo X., Thomas P.D. Protocol Update for large-scale genome and gene function analysis with the PANTHER classification system (v.14.0) Nat. Protoc. 2019;14:703–721. doi: 10.1038/s41596-019-0128-8. PubMed DOI PMC

The Gene Ontology C. Expansion of the Gene Ontology knowledgebase and resources. Nucleic Acids Res. 2017;45:D331–D338. doi: 10.1093/nar/gkw1108. PubMed DOI PMC

Huang da W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009;4:44–57. doi: 10.1038/nprot.2008.211. PubMed DOI

Huang da W., Sherman B.T., Lempicki R.A. Bioinformatics enrichment tools: Paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009;37:1–13. doi: 10.1093/nar/gkn923. PubMed DOI PMC

Lehtimaki J.I., Rajakyla E.K., Tojkander S., Lappalainen P. Generation of stress fibers through myosin-driven reorganization of the actin cortex. Elife. 2021;10:e60710. doi: 10.7554/eLife.60710. PubMed DOI PMC

Jannie K.M., Ellerbroek S.M., Zhou D.W., Chen S., Crompton D.J., Garcia A.J., DeMali K.A. Vinculin-dependent actin bundling regulates cell migration and traction forces. Biochem. J. 2015;465:383–393. doi: 10.1042/BJ20140872. PubMed DOI PMC

Hu C., Zhou H., Liu Y., Huang J., Liu W., Zhang Q., Tang Q., Sheng F., Li G., Zhang R. ROCK1 promotes migration and invasion of nonsmallcell lung cancer cells through the PTEN/PI3K/FAK pathway. Int J. Oncol. 2019;55:833–844. doi: 10.3892/ijo.2019.4864. PubMed DOI PMC

Miyake M., Hori S., Morizawa Y., Tatsumi Y., Toritsuka M., Ohnishi S., Shimada K., Furuya H., Khadka V.S., Deng Y., et al. Collagen type IV alpha 1 (COL4A1) and collagen type XIII alpha 1 (COL13A1) produced in cancer cells promote tumor budding at the invasion front in human urothelial carcinoma of the bladder. Oncotarget. 2017;8:36099–36114. doi: 10.18632/oncotarget.16432. PubMed DOI PMC

Ohlund D., Franklin O., Lundberg E., Lundin C., Sund M. Type IV collagen stimulates pancreatic cancer cell proliferation, migration, and inhibits apoptosis through an autocrine loop. BMC Cancer. 2013;13:154. doi: 10.1186/1471-2407-13-154. PubMed DOI PMC

Wang T., Jin H., Hu J., Li X., Ruan H., Xu H., Wei L., Dong W., Teng F., Gu J., et al. COL4A1 promotes the growth and metastasis of hepatocellular carcinoma cells by activating FAK-Src signaling. J. Exp. Clin. Cancer Res. 2020;39:148. doi: 10.1186/s13046-020-01650-7. PubMed DOI PMC

Liu Y., Zhang J., Chen Y., Sohel H., Ke X., Chen J., Li Y.X. The correlation and role analysis of COL4A1 and COL4A2 in hepatocarcinogenesis. Aging. 2020;12:204–223. doi: 10.18632/aging.102610. PubMed DOI PMC

Brown C.W., Brodsky A.S., Freiman R.N. Notch3 overexpression promotes anoikis resistance in epithelial ovarian cancer via upregulation of COL4A2. Mol. Cancer Res. 2015;13:78–85. doi: 10.1158/1541-7786.MCR-14-0334. PubMed DOI PMC

Ohlund D., Lundin C., Ardnor B., Oman M., Naredi P., Sund M. Type IV collagen is a tumour stroma-derived biomarker for pancreas cancer. Br. J. Cancer. 2009;101:91–97. doi: 10.1038/sj.bjc.6605107. PubMed DOI PMC

Zhou J., Kang X., An H., Lv Y., Liu X. The function and pathogenic mechanism of filamin A. Gene. 2021;784:145575. doi: 10.1016/j.gene.2021.145575. PubMed DOI

Ljepoja B., Schreiber C., Gegenfurtner F.A., Garcia-Roman J., Kohler B., Zahler S., Radler J.O., Wagner E., Roidl A. Inducible microRNA-200c decreases motility of breast cancer cells and reduces filamin A. PLoS ONE. 2019;14:e0224314. doi: 10.1371/journal.pone.0224314. PubMed DOI PMC

Khapchaev A.Y., Shirinsky V.P. Myosin Light Chain Kinase MYLK1: Anatomy, Interactions, Functions, and Regulation. Biochemistry. 2016;81:1676–1697. doi: 10.1134/S000629791613006X. PubMed DOI

Park J., Kim D.H., Kim H.N., Wang C.J., Kwak M.K., Hur E., Suh K.Y., An S.S., Levchenko A. Directed migration of cancer cells guided by the graded texture of the underlying matrix. Nat. Mater. 2016;15:792–801. doi: 10.1038/nmat4586. PubMed DOI PMC

Sundararajan V., Gengenbacher N., Stemmler M.P., Kleemann J.A., Brabletz T., Brabletz S. The ZEB1/miR-200c feedback loop regulates invasion via actin interacting proteins MYLK and TKS5. Oncotarget. 2015;6:27083–27096. doi: 10.18632/oncotarget.4807. PubMed DOI PMC

Stull J.T., Tansey M.G., Tang D.C., Word R.A., Kamm K.E. Phosphorylation of myosin light chain kinase: A cellular mechanism for Ca2+ desensitization. Mol. Cell Biochem. 1993;127–128:229–237. doi: 10.1007/BF01076774. PubMed DOI

Tan X., Tong L., Li L., Xu J., Xie S., Ji L., Fu J., Liu Q., Shen S., Liu Y., et al. Loss of Smad4 promotes aggressive lung cancer metastasis by de-repression of PAK3 via miRNA regulation. Nat. Commun. 2021;12:4853. doi: 10.1038/s41467-021-24898-9. PubMed DOI PMC

Lowy C.M., Oskarsson T. Tenascin C in metastasis: A view from the invasive front. Cell Adh. Migr. 2015;9:112–124. doi: 10.1080/19336918.2015.1008331. PubMed DOI PMC

Nagaharu K., Zhang X., Yoshida T., Katoh D., Hanamura N., Kozuka Y., Ogawa T., Shiraishi T., Imanaka-Yoshida K. Tenascin C induces epithelial-mesenchymal transition-like change accompanied by SRC activation and focal adhesion kinase phosphorylation in human breast cancer cells. Am. J. Pathol. 2011;178:754–763. doi: 10.1016/j.ajpath.2010.10.015. PubMed DOI PMC

Rodriguez de Cordoba S., Marshall P., Rubinstein P. Twenty-six DR beta and 16 DQ beta chain IEF variants and their associated HLA-DR, HLA-DQ, and HLA-Dw specificities. Immunogenetics. 1989;29:49–53. doi: 10.1007/BF02341613. PubMed DOI

Perrot-Applanat M., Di Benedetto M. Autocrine functions of VEGF in breast tumor cells: Adhesion, survival, migration and invasion. Cell Adh. Migr. 2012;6:547–553. doi: 10.4161/cam.23332. PubMed DOI PMC

Carisey A., Tsang R., Greiner A.M., Nijenhuis N., Heath N., Nazgiewicz A., Kemkemer R., Derby B., Spatz J., Ballestrem C. Vinculin regulates the recruitment and release of core focal adhesion proteins in a force-dependent manner. Curr. Biol. 2013;23:271–281. doi: 10.1016/j.cub.2013.01.009. PubMed DOI PMC

Legerstee K., Geverts B., Slotman J.A., Houtsmuller A.B. Dynamics and distribution of paxillin, vinculin, zyxin and VASP depend on focal adhesion location and orientation. Sci. Rep. 2019;9:10460. doi: 10.1038/s41598-019-46905-2. PubMed DOI PMC

Lemos Gomes M., Lopes A., Sobrinho G., Mendes Pedro L. Restenosis of Aorto-renal Venous Grafts: Report of Two Patients Treated by Endovascular Stenting. EJVES Short Rep. 2018;40:3–6. doi: 10.1016/j.ejvssr.2018.07.001. PubMed DOI PMC

Mise N., Savai R., Yu H., Schwarz J., Kaminski N., Eickelberg O. Zyxin is a transforming growth factor-beta (TGF-beta)/Smad3 target gene that regulates lung cancer cell motility via integrin alpha5beta1. J. Biol. Chem. 2012;287:31393–31405. doi: 10.1074/jbc.M112.357624. PubMed DOI PMC

Lin T.C., Yang C.H., Cheng L.H., Chang W.T., Lin Y.R., Cheng H.C. Fibronectin in Cancer: Friend or Foe. Cells. 2019;9:27. doi: 10.3390/cells9010027. PubMed DOI PMC

Drake J.M., Barnes J.M., Madsen J.M., Domann F.E., Stipp C.S., Henry M.D. ZEB1 coordinately regulates laminin-332 and {beta}4 integrin expression altering the invasive phenotype of prostate cancer cells. J. Biol. Chem. 2010;285:33940–33948. doi: 10.1074/jbc.M110.136044. PubMed DOI PMC

Bianchi A., Gervasi M.E., Bakin A. Role of beta5-integrin in epithelial-mesenchymal transition in response to TGF-beta. Cell Cycle. 2010;9:1647–1659. doi: 10.4161/cc.9.8.11517. PubMed DOI

Lin Z., He R., Luo H., Lu C., Ning Z., Wu Y., Han C., Tan G., Wang Z. Integrin-beta5, a miR-185-targeted gene, promotes hepatocellular carcinoma tumorigenesis by regulating beta-catenin stability. J. Exp. Clin. Cancer Res. 2018;37:17. doi: 10.1186/s13046-018-0691-9. PubMed DOI PMC

Zhou M., Niu J., Wang J., Gao H., Shahbaz M., Niu Z., Li Z., Zou X., Liang B. Integrin alphavbeta8 serves as a Novel Marker of Poor Prognosis in Colon Carcinoma and Regulates Cell Invasiveness through the Activation of TGF-beta1. J. Cancer. 2020;11:3803–3815. doi: 10.7150/jca.43826. PubMed DOI PMC

McCarty J.H. alphavbeta8 integrin adhesion and signaling pathways in development, physiology and disease. J. Cell Sci. 2020;133:jcs239434. doi: 10.1242/jcs.239434. PubMed DOI PMC

Kumar V., Soni U.K., Maurya V.K., Singh K., Jha R.K. Integrin beta8 (ITGB8) activates VAV-RAC1 signaling via FAK in the acquisition of endometrial epithelial cell receptivity for blastocyst implantation. Sci. Rep. 2017;7:1885. doi: 10.1038/s41598-017-01764-7. PubMed DOI PMC

Hamill K.J., Paller A.S., Jones J.C. Adhesion and migration, the diverse functions of the laminin alpha3 subunit. Dermatol. Clin. 2010;28:79–87. doi: 10.1016/j.det.2009.10.009. PubMed DOI PMC

Moncho-Amor V., Pintado-Berninches L., Ibanez de Caceres I., Martin-Villar E., Quintanilla M., Chakravarty P., Cortes-Sempere M., Fernandez-Varas B., Rodriguez-Antolin C., de Castro J., et al. Role of Dusp6 Phosphatase as a Tumor Suppressor in Non-Small Cell Lung Cancer. Int. J. Mol. Sci. 2019;20:2036. doi: 10.3390/ijms20082036. PubMed DOI PMC

Horzum U., Ozdil B., Pesen-Okvur D. Step-by-step quantitative analysis of focal adhesions. MethodsX. 2014;1:56–59. doi: 10.1016/j.mex.2014.06.004. PubMed DOI PMC

Yui K., Imataka G., Nakamura H., Ohara N., Naito Y. Eicosanoids Derived From Arachidonic Acid and Their Family Prostaglandins and Cyclooxygenase in Psychiatric Disorders. Curr. Neuropharmacol. 2015;13:776–785. doi: 10.2174/1570159X13666151102103305. PubMed DOI PMC

Wang T., Fu X., Chen Q., Patra J.K., Wang D., Wang Z., Gai Z. Arachidonic Acid Metabolism and Kidney Inflammation. Int. J. Mol. Sci. 2019;20:3683. doi: 10.3390/ijms20153683. PubMed DOI PMC

Kudo I., Murakami M. Prostaglandin E synthase, a terminal enzyme for prostaglandin E2 biosynthesis. J. Biochem. Mol. Biol. 2005;38:633–638. doi: 10.5483/BMBRep.2005.38.6.633. PubMed DOI

Komoto J., Yamada T., Watanabe K., Takusagawa F. Crystal structure of human prostaglandin F synthase (AKR1C3) Biochemistry. 2004;43:2188–2198. doi: 10.1021/bi036046x. PubMed DOI

Koeberle S.C., Gollowitzer A., Laoukili J., Kranenburg O., Werz O., Koeberle A., Kipp A.P. Distinct and overlapping functions of glutathione peroxidases 1 and 2 in limiting NF-kappaB-driven inflammation through redox-active mechanisms. Redox Biol. 2020;28:101388. doi: 10.1016/j.redox.2019.101388. PubMed DOI PMC

Liu R., Xu K.P., Tan G.S. Cyclooxygenase-2 inhibitors in lung cancer treatment: Bench to bed. Eur. J. Pharmacol. 2015;769:127–133. doi: 10.1016/j.ejphar.2015.11.007. PubMed DOI

Mizuno R., Kawada K., Sakai Y. Prostaglandin E2/EP Signaling in the Tumor Microenvironment of Colorectal Cancer. Int. J. Mol. Sci. 2019;20:6254. doi: 10.3390/ijms20246254. PubMed DOI PMC

Mohammed A., Yarla N.S., Madka V., Rao C.V. Clinically Relevant Anti-Inflammatory Agents for Chemoprevention of Colorectal Cancer: New Perspectives. Int. J. Mol. Sci. 2018;19:2332. doi: 10.3390/ijms19082332. PubMed DOI PMC

Nanda N., Dhawan D.K. Role of Cyclooxygenase-2 in colorectal cancer patients. Front. Biosci. 2021;26:706–716. doi: 10.2741/4914. PubMed DOI

Williams C.S., Mann M., DuBois R.N. The role of cyclooxygenases in inflammation, cancer, and development. Oncogene. 1999;18:7908–7916. doi: 10.1038/sj.onc.1203286. PubMed DOI

Fijneman R.J., Cormier R.T. The roles of sPLA2-IIA (Pla2g2a) in cancer of the small and large intestine. Front. Biosci. 2008;13:4144–4174. doi: 10.2741/2998. PubMed DOI

Adler D.H., Cogan J.D., Phillips J.A., 3rd, Schnetz-Boutaud N., Milne G.L., Iverson T., Stein J.A., Brenner D.A., Morrow J.D., Boutaud O., et al. Inherited human cPLA(2alpha) deficiency is associated with impaired eicosanoid biosynthesis, small intestinal ulceration, and platelet dysfunction. J. Clin. Investig. 2008;118:2121–2131. doi: 10.1172/JCI30473. PubMed DOI PMC

Zhan Y., Zheng L., Liu J., Hu D., Wang J., Liu K., Guo J., Zhang T., Kong D. PLA2G4A promotes right-sided colorectal cancer progression by inducing CD39+gammadelta Treg polarization. JCI Insight. 2021;6 doi: 10.1172/jci.insight.148028. PubMed DOI PMC

Zhang W., Wang X., Zhang L., Geng D., Wang Y., Sun D., Sui P., Zhao X., Xin C., Jiang J., et al. Inhibition of PLA2G4A Reduces the Expression of Lung Cancer-Related Cytokines. DNA Cell Biol. 2018;37:1076–1081. doi: 10.1089/dna.2018.4286. PubMed DOI

Mounier C.M., Wendum D., Greenspan E., Flejou J.F., Rosenberg D.W., Lambeau G. Distinct expression pattern of the full set of secreted phospholipases A2 in human colorectal adenocarcinomas: sPLA2-III as a biomarker candidate. Br. J. Cancer. 2008;98:587–595. doi: 10.1038/sj.bjc.6604184. PubMed DOI PMC

Brychtova V., Vojtesek B., Hrstka R. Anterior gradient 2: A novel player in tumor cell biology. Cancer Lett. 2011;304:1–7. doi: 10.1016/j.canlet.2010.12.023. PubMed DOI

Jia M., Guo Y., Zhu D., Zhang N., Li L., Jiang J., Dong Y., Xu Q., Zhang X., Wang M., et al. Pro-metastatic activity of AGR2 interrupts angiogenesis target bevacizumab efficiency via direct interaction with VEGFA and activation of NF-kappaB pathway. Biochim Biophys Acta Mol. Basis Dis. 2018;1864:1622–1633. doi: 10.1016/j.bbadis.2018.01.021. PubMed DOI

Ondrouskova E., Sommerova L., Nenutil R., Coufal O., Bouchal P., Vojtesek B., Hrstka R. AGR2 associates with HER2 expression predicting poor outcome in subset of estrogen receptor negative breast cancer patients. Exp. Mol. Pathol. 2017;102:280–283. doi: 10.1016/j.yexmp.2017.02.016. PubMed DOI

Tian S.B., Tao K.X., Hu J., Liu Z.B., Ding X.L., Chu Y.N., Cui J.Y., Shuai X.M., Gao J.B., Cai K.L., et al. The prognostic value of AGR2 expression in solid tumours: A systematic review and meta-analysis. Sci. Rep. 2017;7:15500. doi: 10.1038/s41598-017-15757-z. PubMed DOI PMC

Bouchard V., Demers M.J., Thibodeau S., Laquerre V., Fujita N., Tsuruo T., Beaulieu J.F., Gauthier R., Vezina A., Villeneuve L., et al. Fak/Src signaling in human intestinal epithelial cell survival and anoikis: Differentiation state-specific uncoupling with the PI3-K/Akt-1 and MEK/Erk pathways. J. Cell Physiol. 2007;212:717–728. doi: 10.1002/jcp.21096. PubMed DOI

Paul R., Luo M., Mo X., Lu J., Yeo S.K., Guan J.L. FAK activates AKT-mTOR signaling to promote the growth and progression of MMTV-Wnt1-driven basal-like mammary tumors. Breast Cancer Res. 2020;22:59. doi: 10.1186/s13058-020-01298-3. PubMed DOI PMC

Webb D.J., Donais K., Whitmore L.A., Thomas S.M., Turner C.E., Parsons J.T., Horwitz A.F. FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly. Nat. Cell Biol. 2004;6:154–161. doi: 10.1038/ncb1094. PubMed DOI

Fessart D., Villamor I., Chevet E., Delom F., Robert J. Integrative analysis of genomic and transcriptomic alterations of AGR2 and AGR3 in cancer. Open Biol. 2022;12:220068. doi: 10.1098/rsob.220068. PubMed DOI PMC

Hanna V.S., Hafez E.A.A. Synopsis of arachidonic acid metabolism: A review. J. Adv. Res. 2018;11:23–32. doi: 10.1016/j.jare.2018.03.005. PubMed DOI PMC

Wang D., Dubois R.N. The role of COX-2 in intestinal inflammation and colorectal cancer. Oncogene. 2010;29:781–788. doi: 10.1038/onc.2009.421. PubMed DOI PMC

Wang D., DuBois R.N. An inflammatory mediator, prostaglandin E2, in colorectal cancer. Cancer J. 2013;19:502–510. doi: 10.1097/PPO.0000000000000003. PubMed DOI PMC

Wang D., DuBois R.N. The role of anti-inflammatory drugs in colorectal cancer. Annu. Rev. Med. 2013;64:131–144. doi: 10.1146/annurev-med-112211-154330. PubMed DOI

Zhang H., Chi J., Hu J., Ji T., Luo Z., Zhou C., Huang L., Dai Z., Li J., Wang G., et al. Intracellular AGR2 transduces PGE2 stimuli to promote epithelial-mesenchymal transition and metastasis of colorectal cancer. Cancer Lett. 2021;518:180–195. doi: 10.1016/j.canlet.2021.06.025. PubMed DOI

Nakanishi M., Rosenberg D.W. Multifaceted roles of PGE2 in inflammation and cancer. Semin. Immunopathol. 2013;35:123–137. doi: 10.1007/s00281-012-0342-8. PubMed DOI PMC

Wang D., DuBois R.N. Role of prostanoids in gastrointestinal cancer. J. Clin. Investig. 2018;128:2732–2742. doi: 10.1172/JCI97953. PubMed DOI PMC

Menter D.G., Dubois R.N. Prostaglandins in cancer cell adhesion, migration, and invasion. Int. J. Cell Biol. 2012;2012:723419. doi: 10.1155/2012/723419. PubMed DOI PMC

Wang Q., Morris R.J., Bode A.M., Zhang T. Prostaglandin Pathways: Opportunities for Cancer Prevention and Therapy. Cancer Res. 2022;82:949–965. doi: 10.1158/0008-5472.CAN-21-2297. PubMed DOI PMC

Alsereihi R., Schulten H.J., Bakhashab S., Saini K., Al-Hejin A.M., Hussein D. Leveraging the Role of the Metastatic Associated Protein Anterior Gradient Homologue 2 in Unfolded Protein Degradation: A Novel Therapeutic Biomarker for Cancer. Cancers. 2019;11:890. doi: 10.3390/cancers11070890. PubMed DOI PMC

Gupta A., Wodziak D., Tun M., Bouley D.M., Lowe A.W. Loss of anterior gradient 2 (Agr2) expression results in hyperplasia and defective lineage maturation in the murine stomach. J. Biol. Chem. 2013;288:4321–4333. doi: 10.1074/jbc.M112.433086. PubMed DOI PMC

Bouchalova P., Sommerova L., Potesil D., Martisova A., Lapcik P., Koci V., Scherl A., Vonka P., Planas-Iglesias J., Chevet E., et al. Characterization of the AGR2 Interactome Uncovers New Players of Protein Disulfide Isomerase Network in Cancer Cells. Mol. Cell Proteom. 2022;21:100188. doi: 10.1016/j.mcpro.2021.100188. PubMed DOI PMC

Moidu N.A., NS A.R., Syafruddin S.E., Low T.Y., Mohtar M.A. Secretion of pro-oncogenic AGR2 protein in cancer. Heliyon. 2020;6:e05000. doi: 10.1016/j.heliyon.2020.e05000. PubMed DOI PMC

Maurel M., Obacz J., Avril T., Ding Y.P., Papadodima O., Treton X., Daniel F., Pilalis E., Horberg J., Hou W., et al. Control of anterior GRadient 2 (AGR2) dimerization links endoplasmic reticulum proteostasis to inflammation. EMBO Mol. Med. 2019;11:e10120. doi: 10.15252/emmm.201810120. PubMed DOI PMC

Barretina J., Caponigro G., Stransky N., Venkatesan K., Margolin A.A., Kim S., Wilson C.J., Lehar J., Kryukov G.V., Sonkin D., et al. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature. 2012;483:603–607. doi: 10.1038/nature11003. PubMed DOI PMC

Forbes S.A., Bhamra G., Bamford S., Dawson E., Kok C., Clements J., Menzies A., Teague J.W., Futreal P.A., Stratton M.R. The Catalogue of Somatic Mutations in Cancer (COSMIC) Curr Protoc Hum. Genet. 2008 doi: 10.1002/0471142905.hg1011s57. PubMed DOI PMC

Schneider C.A., Rasband W.S., Eliceiri K.W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods. 2012;9:671–675. doi: 10.1038/nmeth.2089. PubMed DOI PMC

Sage D., Neumann F.R., Hediger F., Gasser S.M., Unser M. Automatic tracking of individual fluorescence particles: Application to the study of chromosome dynamics. IEEE Trans. Image Process. 2005;14:1372–1383. doi: 10.1109/TIP.2005.852787. PubMed DOI